To potentially use LSD1 inhibitors for DLBCL treatment, it is important to define the role of LSD1 on DLBCL progression, so that therapeutic approaches targeting this demethylase can be applied precisely. Here, KDM1A is linked to diffuse large B-cell lymphoma.